Lutris Pharma Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Employee Data

  • Lutris Pharma has 4 Employees.(i)
  • Lutris Pharma grew their employee count by 0% last year.

Lutris Pharma's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A2353%N/AN/A
#2
N/A4940%N/AN/A
#3
N/A327%N/AN/A
#4
N/A15-6%N/AN/A
#5
N/A4326%N/AN/A
#6
N/A280%N/AN/A
#7
N/A249%N/AN/A
#8
N/A80%N/AN/A
#9
N/A196%N/AN/A
#10
N/A40%N/AN/A
Add Company

What Is Lutris Pharma?

Lutris Pharma is a clinical stage biopharmaceutical company focused on improving anti-cancer therapy effectiveness and quality of life for patients who are being treated with EGFR (Epidermal Growth Factor Receptor) inhibitors or with radiation, where dermal toxicity often leads to a reduction of anti-cancer therapy compliance. The company aims to provide novel topical therapies in order to mitigate these side effects. Lutris Pharma’s lead asset, LUT014, a topical B-Raf Inhibitor, is a proprietary, first-in-class, small molecule currently in a phase 2 clinical trial in metastatic colorectal cancer patients with EGFR inhibitor induced acneiform lesions and a phase 1/2 study for the treatment of radiation-induced dermatitis.

keywords:N/A

N/A

Total Funding

4

Number of Employees

N/A

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.5M4-20%N/A
#2
$0.3M4N/AN/A
#3
$0.5M4-20%N/A
#4
$0.6M4-50%N/A
#5
$0.4M4-20%N/A